Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
LSTA | LISATA THERAPEUTICS, INC. | Buck Kristen K | EVP, R&D and CMO | Jan 09, 2024 | Option Exercise | $3.08 | 5,368 | 16,533 | 56,694 | Jan 11, 2024, 04:11 PM | |
LSTA | LISATA THERAPEUTICS, INC. | Buck Kristen K | EVP, R&D and CMO | Jan 10, 2024 | Option Exercise | $3.00 | 512 | 1,536 | 54,035 | Jan 11, 2024, 04:11 PM | |
LSTA | LISATA THERAPEUTICS, INC. | Buck Kristen K | EVP, R&D and CMO | Sep 01, 2023 | Option Exercise | $2.18 | 2,908 | 6,339 | 32,915 | Sep 05, 2023, 04:02 PM | |
LSTA | LISATA THERAPEUTICS, INC. | Buck Kristen K | EVP, R&D and CMO | Jan 09, 2023 | Option Exercise | $3.00 | 2,147 | 6,441 | 36,335 | Jan 11, 2023, 04:03 PM | |
LSTA | LISATA THERAPEUTICS, INC. | Buck Kristen K | EVP, R&D and CMO | Jan 10, 2023 | Option Exercise | $3.19 | 512 | 1,636 | 35,823 | Jan 11, 2023, 04:03 PM | |
CLBS | CALADRIUS BIOSCIENCES, INC. | Buck Kristen K | EVP, R&D and CMO | Sep 01, 2022 | Option Exercise | $0.50 | 127,959 | 63,980 | 377,203 | Sep 02, 2022, 04:05 PM | |
CLBS | CALADRIUS BIOSCIENCES, INC. | Buck Kristen K | EVP, R&D and CMO | Jan 10, 2022 | Option Exercise | $0.92 | 7,694 | 7,055 | 319,203 | Jan 12, 2022, 04:18 PM | |
CLBS | CALADRIUS BIOSCIENCES, INC. | Buck Kristen K | EVP, R&D and CMO | Sep 01, 2021 | Option Exercise | $1.28 | 50,103 | 64,132 | 262,397 | Sep 03, 2021, 04:04 PM |